These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1601604)

  • 1. Human pharmacokinetics of iodixanol.
    Svaland MG; Haider T; Langseth-Manrique K; Andrew E; Hals PA
    Invest Radiol; 1992 Feb; 27(2):130-3. PubMed ID: 1601604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of iopentol in healthy volunteers.
    Waaler A; Jørgensen NP; Koksvik B; Skinnemoen K; Andrew E
    Acta Radiol Suppl; 1987; 370():113-7. PubMed ID: 2980304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of the non-ionic X-ray contrast media iodixanol and iohexol in patients with severely impaired renal function.
    Nossen JO; Jakobsen JA; Kjaersgaard P; Andrew E; Jacobsen PB; Berg KJ
    Scand J Clin Lab Invest; 1995 Jul; 55(4):341-50. PubMed ID: 7569737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers.
    Scholz P; Weinmann HJ; Mützel W; Staks T
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():211-4. PubMed ID: 2568798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human pharmacokinetics of iohexol. A new nonionic contrast medium.
    Olsson B; Aulie A; Sveen K; Andrew E
    Invest Radiol; 1983; 18(2):177-82. PubMed ID: 6408018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimum conditions for serum clearance of iodixanol, applicable to the estimation of glomerular filtration rate in horses.
    Satoh H; Abe S; Kato M; Saito J; Furuhama K
    Vet Res Commun; 2011 Oct; 35(7):463-8. PubMed ID: 21611831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Iodixanol. A new isotonic x-ray contrast medium].
    Nossen JO; Andrew E; Aakhus T; Berg KJ; Jørgensen NP
    Tidsskr Nor Laegeforen; 1991 Apr; 111(9):1108-11. PubMed ID: 2024256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calculation of glomerular filtration rate in conscious rats by the use of a bolus injection of iodixanol and a single blood sample.
    Katayama R; Yamaguchi N; Yamashita T; Watanabe S; Satoh H; Yamagishi N; Furuhama K
    J Pharmacol Toxicol Methods; 2010; 61(1):59-64. PubMed ID: 19854282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodixanol pharmacokinetics in children.
    Johnson WH; Lloyd TR; Victorica BE; Zales VR; Epstein ML; Leff RD; Ardinger RH; Slovis TL; Johnson JA; Marsters PA
    Pediatr Cardiol; 2001; 22(3):223-7. PubMed ID: 11343148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The X-ray contrast medium iodixanol detects increased colonic permeability equally well as 51Cr-labeled ethylenediaminetetraacetic acid in experimental colitis of rats.
    Andersen R; Hosaka J; Halstensen TS; Stordahl A; Tverdal A; Aabakken L; Laerum F
    Scand J Gastroenterol; 1996 Feb; 31(2):140-6. PubMed ID: 8658036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodixanol 320 results in better renal tolerance and radiodensity than do gadolinium-based contrast media: arteriography in ischemic porcine kidneys.
    Elmståhl B; Nyman U; Leander P; Golman K; Chai CM; Grant D; Doughty R; Pehrson R; Björk J; Almén T
    Radiology; 2008 Apr; 247(1):88-97. PubMed ID: 18292474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal contrast agents for vascular imaging on computed tomography: iodixanol versus iohexol.
    Pannu HK; Thompson RE; Phelps J; Magee CA; Fishman EK
    Acad Radiol; 2005 May; 12(5):576-84. PubMed ID: 15866130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of glomerular filtration rate in calves using the contrast medium iodixanol.
    Imai K; Yamagishi N; Okura N; Fukuda T; Hirata T; Okada K; Sato S; Furuhama K
    Vet J; 2012 Jul; 193(1):174-9. PubMed ID: 22064323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption and excretion of iodixanol after intragastric administration to rats.
    Dunkel JA; Helund IF; Jacobsen PB; Grant D; Walday P; Refsum H
    Acta Radiol Suppl; 1995; 399():253-7. PubMed ID: 8610524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacokinetics and general toxicology of iodixanol.
    Heglund IF; Michelet AA; Blazak WF; Furuhama K; Holtz E
    Acta Radiol Suppl; 1995; 399():69-82. PubMed ID: 8610532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of glomerular filtration rate in rabbits by a single-sample method using iodixanol.
    Michigoshi Y; Katayama R; Yamagishi N; Kato M; Saito J; Satoh H; Furuhama K
    Lab Anim; 2012 Oct; 46(4):341-4. PubMed ID: 23097569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography.
    Sahani DV; Soulez G; Chen KM; Lepanto L; Xu JR; Nelson RC; Grazioli L; Vanzulli A; Heiken JP;
    Invest Radiol; 2007 Dec; 42(12):856-61. PubMed ID: 18007158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of iohexol, a new nonionic radiocontrast agent, in humans.
    Edelson J; Shaw D; Palace G
    J Pharm Sci; 1984 Jul; 73(7):993-5. PubMed ID: 6470969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue distribution and excretion of iotrolan after intravenous and suboccipital injections in animals.
    Weinmann HJ; Scholz P; Mützel W
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():206-10. PubMed ID: 2568796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of iodinated contrast agent properties on renal kinetics and oxygenation.
    Lenhard DC; Frisk AL; Lengsfeld P; Pietsch H; Jost G
    Invest Radiol; 2013 Apr; 48(4):175-82. PubMed ID: 23262792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.